• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZOLL CIRCULATION AUTOPULSE® PLATFORM RESUSCITATION; CARDIAC CHEST COMPRESSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZOLL CIRCULATION AUTOPULSE® PLATFORM RESUSCITATION; CARDIAC CHEST COMPRESSOR Back to Search Results
Model Number MODEL 100
Device Problem Inappropriate or Unexpected Reset (2959)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/24/2019
Event Type  malfunction  
Manufacturer Narrative
Zoll has received the autopulse platform (sn (b)(4)) for investigation.A follow-up report will be submitted when the investigation has been completed.The death was not related to the autopulse device.The autopulse is used as an adjunct to manual cpr in cases of clinical death.The benefit of using the autopulse is that it in part substitutes mechanical compressions for the physical labor of manual chest compressions.If the autopulse did not start or unexpectedly stops compressions, rescuer should revert to manual cpr, which is the standard of care.In this case, during patient use, the autopulse platform (sn (b)(4)) powered on and powered off by itself continuously.The crew reverted to manual cpr.Rosc was not achieved and the patient expired.The autopulse was intended to be used as an adjunct to manual cpr on adult patients.In case of stoppage of autopulse the trained user reverts to manual cpr.The transition from autopulse to manual cpr by trained users is similar to the time necessary for rescuer rotation, and presents the same workflow as manual cpr.Hence, based on available information, the patients' outcome was not negatively impacted by the interruptions when compared to standard of care manual cpr.
 
Event Description
During patient use, the autopulse platform (sn (b)(4)) kept on resetting continuously.The crew reverted to manual cpr.Rosc was not achieved and the patient expired.No further information was provided.
 
Manufacturer Narrative
The reported complaint of "the autopulse platform (sn: (b)(4) kept on resetting continuously" was confirmed during the archive data review, but not during the functional testing.No device malfunction was observed during the testing and the autopulse platform performed as intended.The load sensing system has detected a weight or load imbalance between the two load cells, due to the patient not oriented on the autopulse platform correctly or the patient has shifted during compression or take-up.The root cause for the reported complaint was due to user error.Upon visual inspection, unrelated to the reported complaint, noticed crack on the front enclosure.The probable cause for the physical damage could be due to normal wear and tear of the device or due to the damage sustained by user mishandling.The autopulse platform was manufactured in 2012 and is 7 years old, past the expected service life of 5 years.The front enclosure was replaced to address the physical damage.The autopulse platform passed the initial functional testing without any fault or error.Load cell characterization test indicated both cell modules are functioning within the specification.The archive data review showed occurrence of user advisory (ua) 07 (discrepancy between load 1 and load 2 too large) error message around the customer reported complaint date, thus confirming the customer reported complaint.User advisory is a clearable error message and is designed into the platform to alert the operator that autopulse has detected one of several conditions.Ua07 is an indication that the load sensing system has detected a weight/load imbalance between the two load cells.The recommended actions to take for this type of user advisory are: ensure the patient is properly aligned (armpits on the yellow line), deploy the shoulder restraint to mitigate patient movement and press restart to clear the ua.Following service, the autopulse platform was subjected to the run-in test using the 95% patient large resuscitation test fixture (lrtf) with good known test batteries until discharged without any fault or error.The brake gap inspection was performed and verified the brake gap was within the specification.The autopulse platform passed the final testing without any fault or error.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AUTOPULSE® PLATFORM RESUSCITATION
Type of Device
CARDIAC CHEST COMPRESSOR
Manufacturer (Section D)
ZOLL CIRCULATION
2000 ringwood ave.
san jose CA 95131
MDR Report Key9331155
MDR Text Key167241061
Report Number3010617000-2019-01041
Device Sequence Number1
Product Code DRM
UDI-Device Identifier00849111000512
UDI-Public00849111000512
Combination Product (y/n)N
PMA/PMN Number
K112998
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/15/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberMODEL 100
Device Catalogue Number8700-0730-01
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/31/2019
Date Manufacturer Received11/25/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-